Yingshi Zhang

5PUBLICATIONS
5CO-AUTHORS
Metabolic medicineCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2026
Multi-Targeted Therapeutic Mechanisms of Huangqi Guizhi Wuwu Decoction Against Rheumatoid Arthritis: An Integrated Approach Combining Serum Pharmacochemistry, Network Pharmacology, Metabolomics, and Experimental Validation.

Zihua Xu, Zhenshu Li, Jiameng Qu

|Mar 28, 2025
Editorial Expression of Concern: A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.

Shu Wang, Yingshi Zhang, Tianshu Ren

|Nov 17, 2021
Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis.

Yingshi Zhang, Jiayue Gao, Yu Bao

|Dec 30, 2020
Which Is the Most Appropriate PI3K Inhibitor for Breast Cancer Patients with or without PIK3CA Status Mutant? A Systematic Review and Network Meta-Analysis.

Shu Wang, Mingyue Liu, Siheng Lian

|Jul 02, 2020
A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.

Shu Wang, Yingshi Zhang, Tianshu Ren

Pageof 1

Frequent Collaborators

1 joint publications

Lingyan Jian

1 joint publications

Zihua Xu

1 joint publications

Zhenshu Li

1 joint publications

Qingchun Zhao